Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 23 entries
Sorted by: Best Match Show Resources per page
Different adipose depots: their role in the development of metabolic syndrome and mitochondrial response to hypolipidemic agents.

Journal of obesity

Bjørndal B, Burri L, Staalesen V, Skorve J, Berge RK.
PMID: 21403826
J Obes. 2011;2011:490650. doi: 10.1155/2011/490650. Epub 2011 Feb 15.

Adipose tissue metabolism is closely linked to insulin resistance, and differential fat distributions are associated with disorders like hypertension, diabetes, and cardiovascular disease. Adipose tissues vary in their impact on metabolic risk due to diverse gene expression profiles, leading...

Cite
Bjørndal B, Burri L, Staalesen V, et al. Different adipose depots: their role in the development of metabolic syndrome and mitochondrial response to hypolipidemic agents. J Obes. 2011;2011:490650doi: 10.1155/2011/490650.
Bjørndal, B., Burri, L., Staalesen, V., Skorve, J., & Berge, R. K. (2011). Different adipose depots: their role in the development of metabolic syndrome and mitochondrial response to hypolipidemic agents. Journal of obesity, 2011490650. https://doi.org/10.1155/2011/490650
Bjørndal, Bodil, et al. "Different adipose depots: their role in the development of metabolic syndrome and mitochondrial response to hypolipidemic agents." Journal of obesity vol. 2011 (2011): 490650. doi: https://doi.org/10.1155/2011/490650
Bjørndal B, Burri L, Staalesen V, Skorve J, Berge RK. Different adipose depots: their role in the development of metabolic syndrome and mitochondrial response to hypolipidemic agents. J Obes. 2011;2011:490650. doi: 10.1155/2011/490650. Epub 2011 Feb 15. PMID: 21403826; PMCID: PMC3042633.
Copy Download .nbib Format: NLM
Depressive symptoms and adherence to cardiometabolic therapies across phases of treatment among adults with diabetes: the Diabetes Study of Northern California (DISTANCE).

Patient preference and adherence

Bauer AM, Parker MM, Moffet HH, Schillinger D, Adler NE, Adams AS, Schmittdiel JA, Katon WJ, Karter AJ.
PMID: 28392679
Patient Prefer Adherence. 2017 Mar 24;11:643-652. doi: 10.2147/PPA.S124181. eCollection 2017.

OBJECTIVE: Among adults with diabetes, depression is associated with poorer adherence to cardiometabolic medications in ongoing users; however, it is unknown whether this extends to early adherence among patients newly prescribed these medications. This study examined whether depressive symptoms...

Cite
Bauer AM, Parker MM, Moffet HH, et al. Depressive symptoms and adherence to cardiometabolic therapies across phases of treatment among adults with diabetes: the Diabetes Study of Northern California (DISTANCE). Patient Prefer Adherence. 2017;11:643-652doi: 10.2147/PPA.S124181.
Bauer, A. M., Parker, M. M., Moffet, H. H., Schillinger, D., Adler, N. E., Adams, A. S., Schmittdiel, J. A., Katon, W. J., & Karter, A. J. (2017). Depressive symptoms and adherence to cardiometabolic therapies across phases of treatment among adults with diabetes: the Diabetes Study of Northern California (DISTANCE). Patient preference and adherence, 11643-652. https://doi.org/10.2147/PPA.S124181
Bauer, Amy M, et al. "Depressive symptoms and adherence to cardiometabolic therapies across phases of treatment among adults with diabetes: the Diabetes Study of Northern California (DISTANCE)." Patient preference and adherence vol. 11 (2017): 643-652. doi: https://doi.org/10.2147/PPA.S124181
Bauer AM, Parker MM, Moffet HH, Schillinger D, Adler NE, Adams AS, Schmittdiel JA, Katon WJ, Karter AJ. Depressive symptoms and adherence to cardiometabolic therapies across phases of treatment among adults with diabetes: the Diabetes Study of Northern California (DISTANCE). Patient Prefer Adherence. 2017 Mar 24;11:643-652. doi: 10.2147/PPA.S124181. eCollection 2017. PMID: 28392679; PMCID: PMC5373834.
Copy Download .nbib Format: NLM
REvisiting Lipids in REtinal Diseases: A Focused Review on Age-related Macular Degeneration and Diabetic Retinopathy.

Journal of lipid and atherosclerosis

Park SJ, Park DH.
PMID: 33024733
J Lipid Atheroscler. 2020 Sep;9(3):406-418. doi: 10.12997/jla.2020.9.3.406. Epub 2020 Sep 18.

Dyslipidemia refers to an abnormal amount of lipid in the blood, and the total cholesterol level is defined as the sum of high-density lipoprotein cholesterol, low-density lipoprotein (LDL) cholesterol, and very-LDL cholesterol concentrations. In Korea, the westernization of lifestyle...

Cite
Park SJ, Park DH. REvisiting Lipids in REtinal Diseases: A Focused Review on Age-related Macular Degeneration and Diabetic Retinopathy. J Lipid Atheroscler. 2020;9(3):406-418doi: 10.12997/jla.2020.9.3.406.
Park, S. J., & Park, D. H. (2020). REvisiting Lipids in REtinal Diseases: A Focused Review on Age-related Macular Degeneration and Diabetic Retinopathy. Journal of lipid and atherosclerosis, 9(3), 406-418. https://doi.org/10.12997/jla.2020.9.3.406
Park, Su Jin, and Park, Dong Ho. "REvisiting Lipids in REtinal Diseases: A Focused Review on Age-related Macular Degeneration and Diabetic Retinopathy." Journal of lipid and atherosclerosis vol. 9,3 (2020): 406-418. doi: https://doi.org/10.12997/jla.2020.9.3.406
Park SJ, Park DH. REvisiting Lipids in REtinal Diseases: A Focused Review on Age-related Macular Degeneration and Diabetic Retinopathy. J Lipid Atheroscler. 2020 Sep;9(3):406-418. doi: 10.12997/jla.2020.9.3.406. Epub 2020 Sep 18. PMID: 33024733; PMCID: PMC7521975.
Copy Download .nbib Format: NLM
Rapid Reduction in Use of Antidiabetic Medication after Laparoscopic Sleeve Gastrectomy: The Newfoundland and Labrador Bariatric Surgery Cohort (BaSCo) Study.

The Canadian journal of hospital pharmacy

Dillon C, Peddle J, Twells L, Lester K, Midodzi W, Manning K, Murphy R, Pace D, Smith C, Boone D, Gregory D.
PMID: 25964682
Can J Hosp Pharm. 2015 Mar-Apr;68(2):113-20. doi: 10.4212/cjhp.v68i2.1436.

BACKGROUND: Patients who have undergone bariatric surgery generally need fewer medications as they experience improvement in, or even resolution of, various medical conditions, including type 2 diabetes mellitus, hypertension, and dyslipidemia. Published data on changes in medication use after...

Cite
Dillon C, Peddle J, Twells L, et al. Rapid Reduction in Use of Antidiabetic Medication after Laparoscopic Sleeve Gastrectomy: The Newfoundland and Labrador Bariatric Surgery Cohort (BaSCo) Study. Can J Hosp Pharm. 2015;68(2):113-20doi: 10.4212/cjhp.v68i2.1436.
Dillon, C., Peddle, J., Twells, L., Lester, K., Midodzi, W., Manning, K., Murphy, R., Pace, D., Smith, C., Boone, D., & Gregory, D. (2015). Rapid Reduction in Use of Antidiabetic Medication after Laparoscopic Sleeve Gastrectomy: The Newfoundland and Labrador Bariatric Surgery Cohort (BaSCo) Study. The Canadian journal of hospital pharmacy, 68(2), 113-20. https://doi.org/10.4212/cjhp.v68i2.1436
Dillon, Carla, et al. "Rapid Reduction in Use of Antidiabetic Medication after Laparoscopic Sleeve Gastrectomy: The Newfoundland and Labrador Bariatric Surgery Cohort (BaSCo) Study." The Canadian journal of hospital pharmacy vol. 68,2 (2015): 113-20. doi: https://doi.org/10.4212/cjhp.v68i2.1436
Dillon C, Peddle J, Twells L, Lester K, Midodzi W, Manning K, Murphy R, Pace D, Smith C, Boone D, Gregory D. Rapid Reduction in Use of Antidiabetic Medication after Laparoscopic Sleeve Gastrectomy: The Newfoundland and Labrador Bariatric Surgery Cohort (BaSCo) Study. Can J Hosp Pharm. 2015 Mar-Apr;68(2):113-20. doi: 10.4212/cjhp.v68i2.1436. PMID: 25964682; PMCID: PMC4414072.
Copy Download .nbib Format: NLM
The Use of Primary Care Electronic Health Records for Research: Lipid Medications and Mortality in Elderly Patients.

Pharmacy (Basel, Switzerland)

Hodgkins AJ, Mullan J, Mayne D, Bonney A.
PMID: 31540408
Pharmacy (Basel). 2019 Sep 18;7(3). doi: 10.3390/pharmacy7030134.

General practice electronic health record (EHR) data have significant potential for clinical research. This study demonstrates the feasibility of utilising longitudinal EHR data analysis to address clinically relevant outcomes and uses the relationship between lipid medication prescription and all-cause...

Cite
Hodgkins AJ, Mullan J, Mayne D, et al. The Use of Primary Care Electronic Health Records for Research: Lipid Medications and Mortality in Elderly Patients. Pharmacy (Basel). 2019;7(3)doi: 10.3390/pharmacy7030134.
Hodgkins, A. J., Mullan, J., Mayne, D., & Bonney, A. (2019). The Use of Primary Care Electronic Health Records for Research: Lipid Medications and Mortality in Elderly Patients. Pharmacy (Basel, Switzerland), 7(3), . https://doi.org/10.3390/pharmacy7030134
Hodgkins, Adam J, et al. "The Use of Primary Care Electronic Health Records for Research: Lipid Medications and Mortality in Elderly Patients." Pharmacy (Basel, Switzerland) vol. 7,3 (2019). doi: https://doi.org/10.3390/pharmacy7030134
Hodgkins AJ, Mullan J, Mayne D, Bonney A. The Use of Primary Care Electronic Health Records for Research: Lipid Medications and Mortality in Elderly Patients. Pharmacy (Basel). 2019 Sep 18;7(3). doi: 10.3390/pharmacy7030134. PMID: 31540408; PMCID: PMC6789657.
Copy Download .nbib Format: NLM
Hypolipidemic Agents of Phthalimide Derivatives 6. Effects of Aromatic vs. Non-Aromatic Imides.

Pharmaceutical research

Chapman JM, Wyrick SD, Maguire JH, Cocolas GH, Hall IH.
PMID: 24277360
Pharm Res. 1984 Nov;1(6):267-9. doi: 10.1023/A:1016346018962.

A number of substituted phthalimide, 1, 8-naphthalimide, succinimide and glutarimide derivatives demonstrated significant hypolipidemic activity at 20 mg/kg/ day, I.P. after 16 days dosing. The N-(n-pentyl) succinimide proved to be the most potent analogue of the new compounds, lowering...

Cite
Chapman JM, Wyrick SD, Maguire JH, et al. Hypolipidemic Agents of Phthalimide Derivatives 6. Effects of Aromatic vs. Non-Aromatic Imides. Pharm Res. 1984;1(6):267-9doi: 10.1023/A:1016346018962.
Chapman, J. M., Wyrick, S. D., Maguire, J. H., Cocolas, G. H., & Hall, I. H. (1984). Hypolipidemic Agents of Phthalimide Derivatives 6. Effects of Aromatic vs. Non-Aromatic Imides. Pharmaceutical research, 1(6), 267-9. https://doi.org/10.1023/A:1016346018962
Chapman, J M, et al. "Hypolipidemic Agents of Phthalimide Derivatives 6. Effects of Aromatic vs. Non-Aromatic Imides." Pharmaceutical research vol. 1,6 (1984): 267-9. doi: https://doi.org/10.1023/A:1016346018962
Chapman JM, Wyrick SD, Maguire JH, Cocolas GH, Hall IH. Hypolipidemic Agents of Phthalimide Derivatives 6. Effects of Aromatic vs. Non-Aromatic Imides. Pharm Res. 1984 Nov;1(6):267-9. doi: 10.1023/A:1016346018962. PMID: 24277360.
Copy Download .nbib Format: NLM
A comparative study of omega-3-fatty acids obtained from marine fish and bezafibrate alone and in combination as hypolipidemic agents.

Pakistan journal of pharmaceutical sciences

Saify ZS, Hassan S, Arif M, Ahmad F, Chishti KA, Siddiqui S.
PMID: 16414833
Pak J Pharm Sci. 2000 Jan;13(1):1-11.

The fish oil and its constituents have been studied in detail with special reference to ailments. The discovery of omega-3 fatty acids led to a detailed investigation about its effect and role as anti-cholesterolemic agents. The effect of fish...

Cite
Saify ZS, Hassan S, Arif M, et al. A comparative study of omega-3-fatty acids obtained from marine fish and bezafibrate alone and in combination as hypolipidemic agents. Pak J Pharm Sci. 2000;13(1):1-11
Saify, Z. S., Hassan, S., Arif, M., Ahmad, F., Chishti, K. A., & Siddiqui, S. (2000). A comparative study of omega-3-fatty acids obtained from marine fish and bezafibrate alone and in combination as hypolipidemic agents. Pakistan journal of pharmaceutical sciences, 13(1), 1-11.
Saify, Z S, et al. "A comparative study of omega-3-fatty acids obtained from marine fish and bezafibrate alone and in combination as hypolipidemic agents." Pakistan journal of pharmaceutical sciences vol. 13,1 (2000): 1-11.
Saify ZS, Hassan S, Arif M, Ahmad F, Chishti KA, Siddiqui S. A comparative study of omega-3-fatty acids obtained from marine fish and bezafibrate alone and in combination as hypolipidemic agents. Pak J Pharm Sci. 2000 Jan;13(1):1-11. PMID: 16414833.
Copy Download .nbib Format: NLM
Statins and Fibrates for Diabetic Retinopathy: Protocol for a Systematic Review.

JMIR research protocols

Mozetic V, Freitas CG, Riera R.
PMID: 28228373
JMIR Res Protoc. 2017 Feb 22;6(2):e30. doi: 10.2196/resprot.6650.

BACKGROUND: Diabetic retinopathy (DR) is a common microvascular complication of diabetes mellitus, and more than 75% of patients who have had diabetes for more than 20 years will have some degree of DR. This disease is highly destructive to...

Cite
Mozetic V, Freitas CG, Riera R. Statins and Fibrates for Diabetic Retinopathy: Protocol for a Systematic Review. JMIR Res Protoc. 2017;6(2):e30doi: 10.2196/resprot.6650.
Mozetic, V., Freitas, C. G., & Riera, R. (2017). Statins and Fibrates for Diabetic Retinopathy: Protocol for a Systematic Review. JMIR research protocols, 6(2), e30. https://doi.org/10.2196/resprot.6650
Mozetic, Vania, et al. "Statins and Fibrates for Diabetic Retinopathy: Protocol for a Systematic Review." JMIR research protocols vol. 6,2 (2017): e30. doi: https://doi.org/10.2196/resprot.6650
Mozetic V, Freitas CG, Riera R. Statins and Fibrates for Diabetic Retinopathy: Protocol for a Systematic Review. JMIR Res Protoc. 2017 Feb 22;6(2):e30. doi: 10.2196/resprot.6650. PMID: 28228373; PMCID: PMC5343211.
Copy Download .nbib Format: NLM
[Secondary prevention in acute myocardial infarction].

Acta medica portuguesa

Ferreira R, Ferreira D, Correia MJ, De Sá ME, De Sousa JV, Sousa JV, Tavares MG.
PMID: 11475986
Acta Med Port. 2001 Mar-Apr;14(2):149-69.

Myocardial infarction is still one of the main causes of mortality and morbidity in Western countries. The advances made in the last 30 years have made it possible to reduce mortality significantly (which is currently below two digits) as...

Cite
Ferreira R, Ferreira D, Correia MJ, et al. Prevenção secundária no enfarte agudo do miocárdio. [Secondary prevention in acute myocardial infarction]. Acta Med Port. 2001;14(2):149-69
Ferreira, R., Ferreira, D., Correia, M. J., De Sá, M. E., De Sousa, J. V., Sousa, J. V., & Tavares, M. G. (2001). Prevenção secundária no enfarte agudo do miocárdio. [Secondary prevention in acute myocardial infarction]. Acta medica portuguesa, 14(2), 149-69.
Ferreira, R, et al. "Prevenção secundária no enfarte agudo do miocárdio." [Secondary prevention in acute myocardial infarction]. Acta medica portuguesa vol. 14,2 (2001): 149-69.
Ferreira R, Ferreira D, Correia MJ, De Sá ME, De Sousa JV, Sousa JV, Tavares MG. Prevenção secundária no enfarte agudo do miocárdio. [Secondary prevention in acute myocardial infarction]. Acta Med Port. 2001 Mar-Apr;14(2):149-69. Portuguese. PMID: 11475986.
Copy Download .nbib Format: NLM
Preliminary study about the possible glycemic clinical advantage in using a fixed combination of Berberis aristata and Silybum marianum standardized extracts versus only Berberis aristata in patients with type 2 diabetes.

Clinical pharmacology : advances and applications

Di Pierro F, Putignano P, Villanova N, Montesi L, Moscatiello S, Marchesini G.
PMID: 24277991
Clin Pharmacol. 2013 Nov 19;5:167-74. doi: 10.2147/CPAA.S54308. eCollection 2013.

BACKGROUND: Berberine is an isoquinoline alkaloid widely used to improve the glucidic and lipidic profiles of patients with hypercholesterolemia, metabolic syndrome, and type 2 diabetes. The limitation of berberine seems to be its poor oral bioavailability, which is affected...

Cite
Di Pierro F, Putignano P, Villanova N, et al. Preliminary study about the possible glycemic clinical advantage in using a fixed combination of Berberis aristata and Silybum marianum standardized extracts versus only Berberis aristata in patients with type 2 diabetes. Clin Pharmacol. 2013;5:167-74doi: 10.2147/CPAA.S54308.
Di Pierro, F., Putignano, P., Villanova, N., Montesi, L., Moscatiello, S., & Marchesini, G. (2013). Preliminary study about the possible glycemic clinical advantage in using a fixed combination of Berberis aristata and Silybum marianum standardized extracts versus only Berberis aristata in patients with type 2 diabetes. Clinical pharmacology : advances and applications, 5167-74. https://doi.org/10.2147/CPAA.S54308
Di Pierro, Francesco, et al. "Preliminary study about the possible glycemic clinical advantage in using a fixed combination of Berberis aristata and Silybum marianum standardized extracts versus only Berberis aristata in patients with type 2 diabetes." Clinical pharmacology : advances and applications vol. 5 (2013): 167-74. doi: https://doi.org/10.2147/CPAA.S54308
Di Pierro F, Putignano P, Villanova N, Montesi L, Moscatiello S, Marchesini G. Preliminary study about the possible glycemic clinical advantage in using a fixed combination of Berberis aristata and Silybum marianum standardized extracts versus only Berberis aristata in patients with type 2 diabetes. Clin Pharmacol. 2013 Nov 19;5:167-74. doi: 10.2147/CPAA.S54308. eCollection 2013. PMID: 24277991; PMCID: PMC3838471.
Copy Download .nbib Format: NLM
The impact of hypotestosteronemia on cardiometabolic effects of atorvastatin in men with hypercholesterolemia: a pilot study.

Coronary artery disease

Krysiak R, Kowalcze K, Okopień B.
PMID: 33826536
Coron Artery Dis. 2021 Dec 01;32(8):706-712. doi: 10.1097/MCA.0000000000001031.

BACKGROUND: Hypothyroidism, hyperprolactinemia, macroprolactinemia and low vitamin D status were found to impair pleiotropic effects of hypolipidemic agents. The aim of the current study was to investigate whether cardiometabolic effects of atorvastatin in men are determined by endogenous testosterone.METHODS:...

Cite
Krysiak R, Kowalcze K, Okopień B. The impact of hypotestosteronemia on cardiometabolic effects of atorvastatin in men with hypercholesterolemia: a pilot study. Coron Artery Dis. 2021;32(8):706-712doi: 10.1097/MCA.0000000000001031.
Krysiak, R., Kowalcze, K., & Okopień, B. (2021). The impact of hypotestosteronemia on cardiometabolic effects of atorvastatin in men with hypercholesterolemia: a pilot study. Coronary artery disease, 32(8), 706-712. https://doi.org/10.1097/MCA.0000000000001031
Krysiak, Robert, et al. "The impact of hypotestosteronemia on cardiometabolic effects of atorvastatin in men with hypercholesterolemia: a pilot study." Coronary artery disease vol. 32,8 (2021): 706-712. doi: https://doi.org/10.1097/MCA.0000000000001031
Krysiak R, Kowalcze K, Okopień B. The impact of hypotestosteronemia on cardiometabolic effects of atorvastatin in men with hypercholesterolemia: a pilot study. Coron Artery Dis. 2021 Dec 01;32(8):706-712. doi: 10.1097/MCA.0000000000001031. PMID: 33826536.
Copy Download .nbib Format: NLM
The hypolipidemic activity of benzenetricarboxylic acids in rodents.

Pharmaceutical research

Hall IH, Chapman JM, Gilbert C.
PMID: 24277214
Pharm Res. 1984 Mar;1(2):63-8. doi: 10.1023/A:1016399213993.

A series of benzenetricarboxylic acids was shown to be potent hypolipidemic agents in rodents. Terephthalic acid proved to be one of the more potent agents, lowering serum cholesterol 42% and serum triglyceride 33 % at 20 mg/kg/day for 16...

Cite
Hall IH, Chapman JM, Gilbert C. The hypolipidemic activity of benzenetricarboxylic acids in rodents. Pharm Res. 1984;1(2):63-8doi: 10.1023/A:1016399213993.
Hall, I. H., Chapman, J. M., & Gilbert, C. (1984). The hypolipidemic activity of benzenetricarboxylic acids in rodents. Pharmaceutical research, 1(2), 63-8. https://doi.org/10.1023/A:1016399213993
Hall, I H, et al. "The hypolipidemic activity of benzenetricarboxylic acids in rodents." Pharmaceutical research vol. 1,2 (1984): 63-8. doi: https://doi.org/10.1023/A:1016399213993
Hall IH, Chapman JM, Gilbert C. The hypolipidemic activity of benzenetricarboxylic acids in rodents. Pharm Res. 1984 Mar;1(2):63-8. doi: 10.1023/A:1016399213993. PMID: 24277214.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 23 entries